Safety and efficacy of lenalidomide for patients with relapsed or refractory adult T cell leukemia/lymphoma post allogeneic hematopoietic stem cell transplantation, multi-institutional prospective observational trial

Authors
Category Primary study
Registry of TrialsUMIN Clinical Trials Registry
Year 2017
This article has no abstract
Epistemonikos ID: 7733bb53d7a175c80556ae05c34f8fcc204bf5b1
First added on: Apr 16, 2025